Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
about
Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid IIEndless Resistance. Endless Antibiotics?Assembly and clustering of natural antibiotics guides target identificationComplete genome sequence and expression profile of the commercial lytic enzyme producer Lysobacter enzymogenes M497-1A Novel Spiro-Heterocyclic Compound Identified by the Silkworm Infection Model Inhibits Transcription in Staphylococcus aureusFluorescence imaging for a noninvasive in vivo toxicity-test using a transgenic silkworm expressing green fluorescent proteinNew Structural Templates for Clinically Validated and Novel Targets in Antimicrobial Drug Research and Development.Bioprospecting Red Sea Coastal Ecosystems for Culturable Microorganisms and Their Antimicrobial Potential.Advantages of the Silkworm As an Animal Model for Developing Novel Antimicrobial Agents.Unconventional screening approaches for antibiotic discovery.Lysobacter species: a potential source of novel antibiotics.Comparative pan genome analysis of oral Prevotella species implicated in periodontitis.Total Synthesis and Functional Evaluation of Fourteen Derivatives of Lysocin E: Importance of Cationic, Hydrophobic, and Aromatic Moieties for Antibacterial Activity.D-cycloserine increases the effectiveness of vancomycin against vancomycin-highly resistant Staphylococcus aureus.Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis.In vitro antibacterial activity and in vivo therapeutic effect of Sesbania grandiflora in bacterial infected silkworms.Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA.Quantitative Analysis of Lysobacter Predation.Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.Structure, Function, and Inhibition of Staphylococcus aureus Heptaprenyl Diphosphate Synthase.An invertebrate infection model for evaluating anti-fungal agents against dermatophytosis.An in vivo invertebrate evaluation system for identifying substances that suppress sucrose-induced postprandial hyperglycemia.Indole-Induced Reversion of Intrinsic Multiantibiotic Resistance in Lysobacter enzymogenes.A partial metabolic pathway enables group b streptococcus to overcome quinone deficiency in a host bacterial community.A chemocentric view of the natural product inventory.Three novel polyene macrolides isolated from cultures of Streptomyces lavenduligriseus.Pharmacokinetic parameters explain the therapeutic activity of antimicrobial agents in a silkworm infection model.A novel mutation in the vraS gene of Staphylococcus aureus contributes to reduce susceptibility against daptomycin.Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights.Genome-wide mutant profiling predicts the mechanism of a Lipid II binding antibiotic.In silico identification of lysocin biosynthetic gene cluster from Lysobacter sp. RH2180-5.Antimicrobial Photodynamic Inactivation Mediated by Rose Bengal and Erythrosine Is Effective in the Control of Food-Related Bacteria in Planktonic and Biofilm States
P2860
Q27728149-DA83FF7E-3F1B-485D-9D25-E5C8FF385937Q28822179-F4171556-D93C-45E7-87AF-A65118D9A769Q30044580-03603118-C0B4-4DA0-A999-B7A2A1967865Q33581692-FAABEC2F-7C0A-4D85-BD9C-E0A7316D5319Q33600086-8F0123EF-212D-4FDA-95F4-4714AD4FD2B7Q35711100-6D6E9D59-A462-4C14-A76C-7E86B2CEBCC1Q36153263-59D62D47-EF1E-4D41-9185-14062F0F6B08Q37290920-A3CEF38A-8022-475B-8C89-BB91B809F333Q37683131-BC362ED4-07BD-44D6-B7E6-6B8A5F49AA81Q38534653-37C5B6F1-964A-4674-A336-4DAC791065BEQ38932009-6C3B2B65-FE5B-44CC-A322-910A76D05E5DQ38942884-31BA91FB-871D-4DF4-BC55-CC0AA7B694B6Q39292881-2A4A825C-632C-42EF-8243-AB8B0A5C7CFCQ40182765-A78E7DE9-C63A-406E-869A-5189BDB96673Q40235944-68F58076-2FA6-4352-92CD-726B5ABB695FQ40310973-9CF75902-B15C-41C0-AD4B-9F9965A42D97Q40333300-AC6D153D-F769-483C-8163-A0DDF3299F95Q40364413-713E5E59-FA1B-414A-B4AB-064F93A33AD7Q40672189-7BB4514C-7373-4D54-9057-65D17CAC9095Q40896611-1562A430-DF75-4B00-A440-84FEF9A14070Q41025749-176A281B-A4C7-41AE-9D37-883F2C777193Q41994258-2017CD30-E3BF-4629-B4DB-0B938F559086Q42011505-7860E4C5-17D3-489E-9FE5-2E9ADA873052Q46348386-7D2FBEE0-6C70-47DC-9595-325C9AA057D6Q46529311-771EEC96-3D51-47DC-BBC4-E7AA21D6FBB1Q46965285-3B8B05DD-A581-410B-AC8F-1F63C14EC64BQ48158923-E799F8DF-85CA-456C-98B6-ED509058FD82Q48162718-18D9141E-B3B8-41C6-8CA4-ED35D759D6C1Q48197648-1C12BF66-2FEA-4E56-B7F5-56995491FD69Q48223572-A5CCB82C-492D-420D-828D-20BC6E0A6C1DQ53073432-20AF4CC4-CDEA-417B-AEF0-1C26D61E7294Q54499750-3579EB61-0B4B-4035-90E9-E8FF7520CA0DQ58696575-3449DAEB-62C9-4604-8A2E-4251A32D09BC
P2860
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@ast
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@en
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@nl
type
label
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@ast
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@en
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@nl
prefLabel
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@ast
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@en
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane.
@nl
P2093
P50
P356
P1476
Lysocin E is a new antibiotic that targets menaquinone in the bacterial membrane
@en
P2093
Hiroki Kurihara
Hiroshi Tomoda
Jyunichiro Yasukawa
Kazuhisa Sekimizu
Kenichi Ishii
Kenji Hamase
Makoto Urai
Manabu Souma
Masayuki Inoue
P2888
P304
P356
10.1038/NCHEMBIO.1710
P577
2014-12-08T00:00:00Z